World Ophthalmoplegia Industry is Expected to Grow at a Healthy CAGR of ~ 7.2 % by 2023

Market Research Future has a half cooked research report on the global ophthalmoplegia market. Ophthalmoplegia Market is Expected to Grow at a Healthy CAGR of ~ 7.2 % during the Forecast Period 2017-2023

Ophthalmoplegia Market Information: By Types (External Opthalmoplegia, Internuclear Opthalmoplegia), By Treatment (Surgery, Drug Treatment), By End Users (Hospital & Clinics, Ambulatory Clinics) - Global Forecast Till 2023
Ophthalmoplegia refers to the condition of double or blurred vision due to damage of the ophthalmic nerves. It can be caused by congenital abnormalities, trauma, viral infections, or disorders that affect the nervous system including multiple sclerosis, cerebral tumors, and migraines. Diabetes is one of the major cause of ophthalmoplegia. Increasing prevalence of ophthalmoplegia, increasing geriatric population, and changing lifestyle are the major driver for the growth of the market. Moreover, increasing prevalence of diabetes & other neurological diseases, and increasing government support for research & development have fuelled the market growth. However, high cost of the treatment may hinder the growth of the market over the assessment period.
The global ophthalmoplegia market is expected to grow at a CAGR of ~ 7.2 % during the forecast period 2017-2023.

Get a sample report at https://www.marketresearchfuture.com/sample_request/4216 .

Regional Analysis
The Americas account for a significant share of the market owing to the presence of huge geriatric and diabetic population. Additionally, high healthcare spending and the government support for research & development have fueled the market growth in this region.
Europe is the second largest global ophthalmoplegia market followed by Asia Pacific.
Asia Pacific is the fastest growing market for ophthalmoplegia. According to WHO, in India 41% of children and 45% of elderly people have visual impairment. Japan and Australia are the major contributor to the growth of the market owing to well-developed healthcare sector and high health care expenditure.
The Middle East & Africa holds the lowest share in the market due to limited availability of medical facilities. Saudi Arabia, UAE, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
Taste the market data and market information presented through more than 90 market data tables and figures spread over 110 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “global ophthalmoplegia market” research report – Forecast till 2023.
Segmentation
The global ophthalmoplegia market has been segmented on the basis of types, treatments, and end users.
On the basis of types, the market is segmented into external ophthalmoplegia and internuclear ophthalmoplegia. External ophthalmoplegia is further segmented into superior recti, inferior recti, medial recti, lateral recti, inferior oblique, and superior oblique muscles.
On the basis of treatments, the market is segmented into surgery, drug treatment, and others. The surgery is further segmented into strabismus surgery and others.
On the basis of end users the market is segmented into hospital & clinics, ambulatory clinics, and others.

Key Players
Some of key players profiled in the report are Abbott (US), Novartis AG (Switzerland), ZEISS International (Germany), Valeant Pharmaceuticals International, Inc. (US), Amritt, Inc. (US), Medline Industries, Inc. (US), ALLERGAN (Ireland), and Johnson & Johnson (US).

Browse Complete Report at https://www.marketresearchfuture.com/reports/ophthalmoplegia-market-4216 .

Market Scenario
Ophthalmoplegia, also referred as extra ocular muscle palsy, is a paralysis of the extra ocular muscles that control movements of eyes. In this condition, nerve fibers that coordinate both eyes in horizontal movements looking from side to side- are damaged. A number of devices and treatments are available in the market, which can cure or improve the eyesight of the patient. The Global ophthalmoplegia market is driven by increasing number of people with ophthalmoplegia and increasing geriatric population. According to the World Health Organization in 2010, about 250 million people of over 50 years were suffering from visual impairment. Around 80% people in many of the developing countries have eye sight problems; of which nearly 50% of the people are not able to take treatment due to huge cost of the surgeries. Increasing prevalence of eye sight affecting diseases, for instance, diabetes and rapid developments in technology have fuelled the growth of the market. On the other hand, high cost of the treatment and availability of cheap alternative treatment may slow the growth of the market.
The global ophthalmoplegia market is expected to grow at a CAGR of ~ 7.2 % during the forecast period 2017-2023.

Intended Audience
• Ophthalmic device manufacturers & suppliers
• Research and development (R&D) companies
• Hospitals and clinics
• Academic institutes and universities

Make an Inquiry at https://www.marketresearchfuture.com/enquiry/4216 .

The report for the global ophthalmoplegia market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

About us
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand
Market Research Future
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: Akash.Anand@Marketresearchfuture.Com
Web: Https://Www.Marketresearchfuture.Com

This release was published on openPR.